Skip to main content

Table 4 Association between patient characteristics and time of severe manifestation

From: Prevalence and risk factors related to poor outcome of patients with severe Plasmodium vivax infection: a systematic review, meta-analysis, and analysis of case reports

Patient Characteristics

Time of severe manifestation

P-value*

Before treatment

After treatment

Before and after treatment

ARDS

 - Yes

8 (36.4)

9 (40.9)

5 (22.7)

0.002

 - No

42 (77.8)

7 (13)

5 (9.3)

 

Renal failure

 - Yes

22 (78.6)

1 (3.6)

5 (17.9)

0.016

 - No

28 (58.3)

15 (31.2)

5 (10.4)

 

Bleeding

 - Yes

2 (25)

2 (25)

4 (50)

0.003

 - No

48 (70.6)

14 (20.6)

6 (8.8)

 

Headache

 - Yes

4 (33.3)

6 (50)

2 (16.7)

0.018

 - No

46 (71.9)

10 (15.6)

8 (12.5)

 

Rash

 - Yes

4 (57.1)

0

3 (42.9)

0.032

 - No

46 (66.7)

16 (23.2)

10 (10.1)

 

Urine (anuria/oliguria)

 - Yes

15 (78.9)

0

4 (21.1)

0.027

 - No

35 (61.4)

16 (28.1)

6 (10.5)

 
  1. *Pearson Chi-Square